Bruceine D inhibits tumor growth and stem cell‐like traits of osteosarcoma through inhibition of STAT3 signaling pathway
Abstract Patients with osteosarcoma exhibiting resistance to chemotherapy or presenting with metastasis usually have a poor prognosis. Osteosarcoma stem cells (OSCs) are a potential cause of tumor metastasis, relapse, and chemotherapy resistance. Therefore, it is necessary to develop novel therapeut...
Main Authors: | Shangyu Wang, Hongzhi Hu, Binlong Zhong, Deyao Shi, Xiangcheng Qing, Cheng Cheng, Xiangyu Deng, Zhicai Zhang, Zengwu Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-12-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2612 |
Similar Items
-
Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas
by: Saisai Tian, et al.
Published: (2020-07-01) -
Finding a Potential Bruceine D Inhibitor for Apoptotic Resistance Protein Pancreatic Cancer Based on Molecular Docking
by: Armi Wulanawati, et al.
Published: (2018-08-01) -
A brief overview of antitumoral actions of bruceine D
by: Zi Wayne Sin, et al.
Published: (2020-08-01) -
Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway
by: Zhang C, et al.
Published: (2019-12-01) -
Costunolide inhibits osteosarcoma growth and metastasis via suppressing STAT3 signal pathway
by: Xinmeng Jin, et al.
Published: (2020-01-01)